BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24577004)

  • 1. Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP.
    De Carolis E; Hensgens LA; Vella A; Posteraro B; Sanguinetti M; Senesi S; Tavanti A
    Med Mycol; 2014 Feb; 52(2):123-30. PubMed ID: 24577004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis.
    Asadzadeh M; Ahmad S; Hagen F; Meis JF; Al-Sweih N; Khan Z
    PLoS One; 2015; 10(11):e0142880. PubMed ID: 26580965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts,
    Arastehfar A; Khodavaisy S; Daneshnia F; Najafzadeh MJ; Mahmoudi S; Charsizadeh A; Salehi MR; Zarrinfar H; Raeisabadi A; Dolatabadi S; Zare Shahrabadi Z; Zomorodian K; Pan W; Hagen F; Boekhout T
    Front Cell Infect Microbiol; 2019; 9():264. PubMed ID: 31417877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism.
    Prakash A; Sharma C; Singh A; Kumar Singh P; Kumar A; Hagen F; Govender NP; Colombo AL; Meis JF; Chowdhary A
    Clin Microbiol Infect; 2016 Mar; 22(3):277.e1-9. PubMed ID: 26548511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry vs conventional methods in the identification of Candida non-albicans].
    Martínez-Lamas L; Pérez del Molino ML; Pardo F; Varela E; Regueiro BJ
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):568-72. PubMed ID: 21782293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infections.
    Pulcrano G; Iula DV; Vollaro A; Tucci A; Cerullo M; Esposito M; Rossano F; Catania MR
    J Microbiol Methods; 2013 Sep; 94(3):262-6. PubMed ID: 23845229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALDI-TOF mass spectrometry and microsatellite markers to evaluate Candida parapsilosis transmission in neonatal intensive care units.
    Pulcrano G; Roscetto E; Iula VD; Panellis D; Rossano F; Catania MR
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):2919-28. PubMed ID: 22644055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the MALDI-TOF VITEK MS™ system for the identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis from bloodstream infections.
    Nobrega de Almeida Júnior J; de Souza LB; Motta AL; Rossi F; Romano Di Gioia TS; Benard G; Del Negro GM
    J Microbiol Methods; 2014 Oct; 105():105-8. PubMed ID: 25072839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Bader O; Weig M; Taverne-Ghadwal L; Lugert R; Gross U; Kuhns M
    Clin Microbiol Infect; 2011 Sep; 17(9):1359-65. PubMed ID: 20946411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species.
    Lacroix C; Gicquel A; Sendid B; Meyer J; Accoceberry I; François N; Morio F; Desoubeaux G; Chandenier J; Kauffmann-Lacroix C; Hennequin C; Guitard J; Nassif X; Bougnoux ME
    Clin Microbiol Infect; 2014 Feb; 20(2):153-8. PubMed ID: 23594150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals.
    Sendid B; Ducoroy P; François N; Lucchi G; Spinali S; Vagner O; Damiens S; Bonnin A; Poulain D; Dalle F
    Med Mycol; 2013 Jan; 51(1):25-32. PubMed ID: 22703164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis.
    Quiles-Melero I; García-Rodríguez J; Gómez-López A; Mingorance J
    Eur J Clin Microbiol Infect Dis; 2012 Jan; 31(1):67-71. PubMed ID: 21547602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-Poor Setting.
    Sow D; Fall B; Ndiaye M; Ba BS; Sylla K; Tine R; Lô AC; Abiola A; Wade B; Dieng T; Dieng Y; Ndiaye JL; Hennequin C; Gaye O; Faye B
    Mycopathologia; 2015 Oct; 180(3-4):173-9. PubMed ID: 26016846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of strains of the Candida parapsilosis group of the BCCM/IHEM collection by MALDI-TOF MS.
    Hendrickx M; Goffinet JS; Swinne D; Detandt M
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):544-8. PubMed ID: 21767712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of mass spectrometry: MALDI-TOF MS for fast and reliable yeast identification].
    Relloso MS; Nievas J; Fares Taie S; Farquharson V; Mujica MT; Romano V; Zarate MS; Smayevsky J
    Rev Argent Microbiol; 2015; 47(2):103-7. PubMed ID: 25882136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) and Bayesian phylogenetic analysis to characterize Candida clinical isolates.
    Angeletti S; Lo Presti A; Cella E; Dicuonzo G; Crea F; Palazzotti B; Dedej E; Ciccozzi M; De Florio L
    J Microbiol Methods; 2015 Dec; 119():214-22. PubMed ID: 26551247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
    Bonfietti LX; Martins MDA; Szeszs MW; Pukiskas SBS; Purisco SU; Pimentel FC; Pereira GH; Silva DC; Oliveira L; Melhem MSC
    J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of mass spectrometry for the identification of clinically interesting yeasts].
    Galán F; García-Agudo L; Guerrero I; Marín P; García-Tapia A; García-Martos P; Rodríguez-Iglesias M
    Enferm Infecc Microbiol Clin; 2015; 33(6):372-8. PubMed ID: 25444360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities.
    Ge YP; Boekhout T; Zhan P; Lu GX; Shen YN; Li M; Shao HF; Liu WD
    Med Mycol; 2012 Jan; 50(1):56-66. PubMed ID: 21728755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.